234 related articles for article (PubMed ID: 25368386)
21. Quantitative measurement of spliced XBP1 mRNA as an indicator of endoplasmic reticulum stress.
Hirota M; Kitagaki M; Itagaki H; Aiba S
J Toxicol Sci; 2006 May; 31(2):149-56. PubMed ID: 16772704
[TBL] [Abstract][Full Text] [Related]
22. Unconventional splicing of XBP1 mRNA occurs in the cytoplasm during the mammalian unfolded protein response.
Uemura A; Oku M; Mori K; Yoshida H
J Cell Sci; 2009 Aug; 122(Pt 16):2877-86. PubMed ID: 19622636
[TBL] [Abstract][Full Text] [Related]
23. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
24. Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges.
Barua D; Gupta A; Gupta S
Cancer Lett; 2020 Aug; 486():29-37. PubMed ID: 32446861
[TBL] [Abstract][Full Text] [Related]
25. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
Bouker KB; Skaar TC; Fernandez DR; O'Brien KA; Riggins RB; Cao D; Clarke R
Cancer Res; 2004 Jun; 64(11):4030-9. PubMed ID: 15173018
[TBL] [Abstract][Full Text] [Related]
26. Spliced or Unspliced, That Is the Question: The Biological Roles of XBP1 Isoforms in Pathophysiology.
Luo X; Alfason L; Wei M; Wu S; Kasim V
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269888
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
Yamaguchi N; Nakayama Y; Yamaguchi N
J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
[TBL] [Abstract][Full Text] [Related]
28. ATF6alpha induces XBP1-independent expansion of the endoplasmic reticulum.
Bommiasamy H; Back SH; Fagone P; Lee K; Meshinchi S; Vink E; Sriburi R; Frank M; Jackowski S; Kaufman RJ; Brewer JW
J Cell Sci; 2009 May; 122(Pt 10):1626-36. PubMed ID: 19420237
[TBL] [Abstract][Full Text] [Related]
29. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.
Nathan S; Ma Y; Tomita YA; De Oliveira E; Brown ML; Rosen EM
Breast Cancer Res Treat; 2017 Dec; 166(3):681-693. PubMed ID: 28808806
[TBL] [Abstract][Full Text] [Related]
30. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
[TBL] [Abstract][Full Text] [Related]
31. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
Chen X; Iliopoulos D; Zhang Q; Tang Q; Greenblatt MB; Hatziapostolou M; Lim E; Tam WL; Ni M; Chen Y; Mai J; Shen H; Hu DZ; Adoro S; Hu B; Song M; Tan C; Landis MD; Ferrari M; Shin SJ; Brown M; Chang JC; Liu XS; Glimcher LH
Nature; 2014 Apr; 508(7494):103-107. PubMed ID: 24670641
[TBL] [Abstract][Full Text] [Related]
32. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
34. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
Gionet N; Jansson D; Mader S; Pratt MA
J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
[TBL] [Abstract][Full Text] [Related]
35. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.
Zhao N; Cao J; Xu L; Tang Q; Dobrolecki LE; Lv X; Talukdar M; Lu Y; Wang X; Hu DZ; Shi Q; Xiang Y; Wang Y; Liu X; Bu W; Jiang Y; Li M; Gong Y; Sun Z; Ying H; Yuan B; Lin X; Feng XH; Hartig SM; Li F; Shen H; Chen Y; Han L; Zeng Q; Patterson JB; Kaipparettu BA; Putluri N; Sicheri F; Rosen JM; Lewis MT; Chen X
J Clin Invest; 2018 Apr; 128(4):1283-1299. PubMed ID: 29480818
[TBL] [Abstract][Full Text] [Related]
37. The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.
Thewes V; Simon R; Hlevnjak M; Schlotter M; Schroeter P; Schmidt K; Wu Y; Anzeneder T; Wang W; Windisch P; Kirchgäßner M; Melling N; Kneisel N; Büttner R; Deuschle U; Sinn HP; Schneeweiss A; Heck S; Kaulfuss S; Hess-Stumpp H; Okun JG; Sauter G; Lykkesfeldt AE; Zapatka M; Radlwimmer B; Lichter P; Tönjes M
Oncogene; 2017 Jul; 36(29):4124-4134. PubMed ID: 28319069
[TBL] [Abstract][Full Text] [Related]
38. Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity.
Fedeles SV; So JS; Shrikhande A; Lee SH; Gallagher AR; Barkauskas CE; Somlo S; Lee AH
J Clin Invest; 2015 May; 125(5):1955-67. PubMed ID: 25844898
[TBL] [Abstract][Full Text] [Related]
39. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
40. XBP1U inhibits the XBP1S-mediated upregulation of the iNOS gene expression in mammalian ER stress response.
Guo F; Lin EA; Liu P; Lin J; Liu C
Cell Signal; 2010 Dec; 22(12):1818-28. PubMed ID: 20637858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
